THE INTERRELATIONSHIP BETWEEN THE ORAL MICROBIOME AND RHEUMATOID ARTHRITIS: EXPLORING MUTUAL INFLUENCES AND CLINICAL IMPLICATIONS
Abstract
Introduction and objective: Periodontitis (PD) is caused by dysbiosis of the oral microbiome (OMB). The prevalence of PD is increased in RA patients. Both conditions have the ability to activate common inflammatory pathways. The OMB shift contributes to more severe course of PD and RA. This paper aims to summarize the impact of OMB on chronic inflammation in the pathogenesis of PD and RA.
Description of the state of knowledge: The OMB can influence chronic inflammation and protein citrullination. The presence of antibodies against citrullinated peptides (ACPA) correlates with an increased incidence and severity of periodontitis. While numerous studies have reported a relationship between the OMB, PD and RA, the role of specific bacteria in RA remains unclear.
Methodology: A literature review was conducted using two databases - PubMed and Google Scholar - with search terms such as "oral microbiome”, “rheumatoid arthritis", "periodontal health”, “oral microbiota”, “periodontal disease”. Articles published within the last eight years were prioritized.
Conclusions: PD is more prevalent and severe particularly in ACPA-positive RA patients. Alterations in OMB are associated with systemic inflammation, contributing to RA progression. and worsening periodontal conditions. Periodontal treatment shows a potential to reduce RA activity, emphasizing the importance of dental care in RA. Anti-inflammatory treatments may restore oral homeostasis. Targeting the OMB offers a potential for managing RA and PD. Further research is needed to establish guidelines for personalized therapies and prophylaxis.
References
Hajishengallis, G. (2015). Periodontitis: From microbial immune subversion to systemic inflammation. Nature Reviews Immunology, 15(1), 30–44. https://doi.org/10.1038/nri3785
Nik-Azis, N. M., Mohd, N., Baharin, B., Said, M. S. M., & Mohd Fadzilah, F. (2021). Periodontal disease in seropositive rheumatoid arthritis: Scoping review of the epidemiological evidence. Germs, 11(2), 266–286. https://doi.org/10.18683/germs.2021.1263
Papapanou, P. N., Sanz, M., Buduneli, N., Dietrich, T., Feres, M., Fine, D. H., Flemmig, T. F., Garcia, R., Giannobile, W. V., Graziani, F., Greenwell, H., Herrera, D., Kao, R. T., Kebschull, M., Kinane, D. F., Kirkwood, K. L., Kocher, T., Kornman, K. S., Kumar, P. S., ... Tonetti, M. S. (2018). Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the classification of periodontal and peri-implant diseases and conditions. Journal of Periodontology, 89(Suppl 1), S173–S182. https://doi.org/10.1002/JPER.17-0721
Smolen, J. S., Aletaha, D., & McInnes, I. B. (2016). Rheumatoid arthritis. Lancet, 388(10055), 2023–2038. https://doi.org/10.1016/S0140-6736(16)30173-8
Kucharz, E. J., & Puszczewicz, M. (Eds.). (2016). Rheumatology (2nd ed., Chapter: Rheumatoid arthritis). Medical Tribune Poland.
Wu, D., Luo, Y., Li, T., Zhao, X., Lv, T., Fang, G., Ou, P., Li, H., Luo, X., Huang, A., & Pang, Y. (2022). Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Frontiers in Immunology, 13, 1051082. https://doi.org/10.3389/fimmu.2022.1051082
Yoshitomi, H. (2019). Regulation of immune responses and chronic inflammation by fibroblast-like synoviocytes. Frontiers in Immunology, 10, 1395. https://doi.org/10.3389/fimmu.2019.01395
Eriksson, K., Fei, G., Lundmark, A., Benchimol, D., Lee, L., Hu, Y. O. O., Kats, A., Saevarsdottir, S., Catrina, A. I., Klinge, B., Andersson, A. F., Klareskog, L., Lundberg, K., Jansson, L., & Yucel-Lindberg, T. (2019). Periodontal health and oral microbiota in patients with rheumatoid arthritis. Journal of Clinical Medicine, 8(5), 630. https://doi.org/10.3390/jcm8050630
Ogrendik, M., Kokino, S., Ozdemir, F., Bird, P. S., & Hamlet, S. (2005). Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. MedGenMed, 7(2), 2.
Nik-Azis, N. M., Mohd, N., Mohd Fadzilah, F., Haflah, N. H. M., Said, M. S. M., & Baharin, B. (2021). Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study. PLoS One, 16(6), e0252859. https://doi.org/10.1371/journal.pone.0252859
Mikuls, T. R., Payne, J. B., Yu, F., Thiele, G. M., Reynolds, R. J., Cannon, G. W., Markt, J., McGowan, D., Kerr, G. S., Redman, R. S., Reimold, A., Griffiths, G., Beatty, M., Gonzalez, S., Bergman, D. A., Hamilton, B. C., Erickson, A. R., Sokolove, J., Robinson, W., ... O'Dell, J. R. (2014). Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis & Rheumatology, 66(5), 1090–1100. https://doi.org/10.1002/art.38348
Queiroz-Junior, C. M., Madeira, M. F. M., Coelho, F. M., Costa, V. V., Bessoni, R. L. C., Sousa, L. F. d. C., Garlet, G. P., Souza, D. G. d., Teixeira, M. M., & Silva, T. A. (2011). Experimental arthritis triggers periodontal disease in mice: Involvement of TNF-α and the oral microbiota. Journal of Immunology, 187(7), 3821–3830. https://doi.org/10.4049/jimmunol.1101195
Corrêa, J. D., Fernandes, G. R., Calderaro, D. C., Mendonça, S. M. S., Silva, J. M., Albiero, M. L., Cunha, F. Q., Xiao, E., Ferreira, G. A., Teixeira, A. L., Mukherjee, C., Leys, E. J., & Silva, T. A. (2019). Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients. Scientific Reports, 9, 8379. https://doi.org/10.1038/s41598-019-44674-6
Golub, L. M., Payne, J. B., Reinhardt, R. A., & Nieman, G. (2006). Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical “two-hit” model. Journal of Dental Research, 85(2), 102–105. https://doi.org/10.1177/154405910608500201
Graves, T., Corrêa, J. D., & Silva, T. A. (2018). The oral microbiota is modified by systemic diseases. Journal of Dental Research, 98(2), 148–156. https://doi.org/10.1177/0022034518805739
Disale, P. R., Zope, S. A., Suragimath, G., Varma, A. S., & Pisal, A. (2020). Prevalence and severity of periodontitis in patients with established rheumatoid arthritis and osteoarthritis. Journal of Family Medicine and Primary Care, 9(6), 2919–2925. https://doi.org/10.4103/jfmpc.jfmpc_398_20
Paksoy, T., Ustaoglu, G., Tasci, M., Demirci, M., Unlu, O., & Yasar, M. F. (2023). Assessment of Epstein–Barr virus, Candida albicans, and some periodontal pathogens in rheumatoid arthritis patients with periodontitis. North Clinics of Istanbul, 10(4), 490–500. https://doi.org/10.14744/nci.2023.58998
Dissick, A., Redman, R. S., Jones, M., Rangan, B. V., Reimold, A., Griffiths, G. R., Mikuls, T. R., Amdur, R. L., Richards, J. S., & Kerr, G. S. (2010). Association of periodontitis with rheumatoid arthritis: A pilot study. Journal of Periodontology, 81(2), 223–230. https://doi.org/10.1902/jop.2009.090309
Scher, J. U., Ubeda, C., Equinda, M., Khanin, R., Buischi, Y., Viale, A., Lipuma, L., Attur, M., Pillinger, M. H., Weissmann, G., Littman, D. R., Pamer, E. G., Bretz, W. A., & Abramson, S. B. (2012). Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis & Rheumatism, 64(10), 3083–3094. https://doi.org/10.1002/art.34539
Rooney, C. M., Mankia, K., & Emery, P. (2020). The role of the microbiome in driving RA-related autoimmunity. Frontiers in Cell and Developmental Biology, 8, 538130. https://doi.org/10.3389/fcell.2020.538130
Aggarwal, R., Liao, K., Nair, R., Ringold, S., & Costenbader, K. H. (2009). Anti-citrullinated peptide antibody (ACPA) assays and their role in the diagnosis of rheumatoid arthritis. Arthritis & Rheumatism, 61(11), 1472–1483. https://doi.org/10.1002/art.24827
Catrina, A. I., Svensson, C. I., Malmström, V., Schett, G., & Klareskog, L. (2017). Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nature Reviews Rheumatology, 13(2), 79–86. https://doi.org/10.1038/nrrheum.2016.200
Patschan, S., Bothmann, L., Patschan, D., Henze, E., Schmalz, G., Ritter, O., & Ziebolz, D. (2020). Association of cytokine patterns and clinical/laboratory parameters, medication and periodontal burden in patients with rheumatoid arthritis (RA). Odontology, 108(3), 441–449. https://doi.org/10.1007/s10266-020-00517-9
van Zanten, A., Arends, S., Roozendaal, C., Limburg, P. C., Maas, F., Trouw, L. A., Toes, R. E. M., Huizinga, T. W. J., Bootsma, H., & Brouwer, E. (2017). Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands. Annals of the Rheumatic Diseases, 76(7), 1184–1190. https://doi.org/10.1136/annrheumdis-2016-20999
Terao, C., Ohmura, K., Ikari, K., Kawaguchi, T., Takahashi, M., Setoh, K., Nakayama, T., Kosugi, S., Sekine, A., Tabara, Y., Taniguchi, A., Momohara, S., Yamanaka, H., Yamada, R., Matsuda, F., & Mimori, T.; Nagahama Study Group. (2014). Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult population. Arthritis Care & Research, 66(12), 1818–1827. https://doi.org/10.1002/acr.22385
Källberg, H., Ding, B., Padyukov, L., Bengtsson, C., Rönnelid, J., Klareskog, L., & Alfredsson, L.; EIRA Study Group. (2010). Smoking is a major preventable risk factor for rheumatoid arthritis: Estimations of risks after various exposures to cigarette smoke. Annals of the Rheumatic Diseases, 70(3), 508–511. https://doi.org/10.1136/ard.2009.120899
Scaf de Molon, R., Rossa, C., Jr, Thurlings, R. M., Cirelli, J. A., & Koenders, M. I. (2019). Linkage of periodontitis and rheumatoid arthritis: Current evidence and potential biological interactions. International Journal of Molecular Sciences, 20(18), 4541. https://doi.org/10.3390/ijms20184541
Koziel, J., Mydel, P., & Potempa, J. (2014). The link between periodontal disease and rheumatoid arthritis: An updated review. Current Rheumatology Reports, 16(3), 408. https://doi.org/10.1007/s11926-014-0408-9
Farquharson, D., Butcher, J. P., & Culshaw, S. (2012). Periodontitis, Porphyromonas, and the pathogenesis of rheumatoid arthritis. Mucosal Immunology, 5(2), 112–120. https://doi.org/10.1038/mi.2011.66
González-Febles, J., & Sanz, M. (2021). Periodontitis and rheumatoid arthritis: What have we learned about their connection and their treatment? Periodontology 2000, 87(1), 181–203. https://doi.org/10.1111/prd.12385
Desclos-Theveniau, M., Bonnaure-Mallet, M., & Meuric, V. (2020). Protein arginine deiminase of oral microbiome plays a causal role in the polyarthritis rheumatoid initiating. Med Sci (Paris), 36(5), 465–471. https://doi.org/10.1051/medsci/2020078
Nesse, W., Westra, J., van der Wal, J. E., Abbas, F., Nicholas, A. P., Vissink, A., & Brouwer, E. (2012). The periodontium of periodontitis patients contains citrullinated proteins which may play a role in ACPA (anti-citrullinated protein antibody) formation. Journal of Clinical Periodontology, 39(7), 599–607. https://doi.org/10.1111/j.1600-051X.2012.01885.x
Kriebel, K., Hieke, C., Müller-Hilke, B., Nakata, M., & Kreikemeyer, B. (2018). Oral biofilms from symbiotic to pathogenic interactions and associated disease—Connection of periodontitis and rheumatic arthritis by peptidylarginine deiminase. Frontiers in Microbiology, 9, 53. https://doi.org/10.3389/fmicb.2018.00053
Gonzales, J. R., Groeger, S., Johansson, A., & Meyle, J. (2014). T helper cells from aggressive periodontitis patients produce higher levels of interleukin-1 beta and interleukin-6 in interaction with Porphyromonas gingivalis. Clinical Oral Investigations, 18(7), 1835–1843. https://doi.org/10.1007/s00784-013-1162-5
Marchesan, J. T., Gerow, E. A., Schaff, R., Taut, A. D., Shin, S.-Y., Sugai, J., Brand, D., Burberry, A., Jorns, J., Lundy, S. K., Nuñez, G., Fox, D. A., & Giannobile, W. V. (2013). Porphyromonas gingivalis oral infection exacerbates the development and severity of collagen-induced arthritis. Arthritis Research & Therapy, 15(6), R186. https://doi.org/10.1186/ar4376
Cantley, M. D., Haynes, D. R., Marino, V., & Bartold, P. M. (2011). Pre-existing periodontitis exacerbates experimental arthritis in a mouse model. Journal of Clinical Periodontology, 38(6), 532–541. https://doi.org/10.1111/j.1600-051X.2011.01714.x
Engström, M., Eriksson, K., Lee, L., Hermansson, M., Johansson, A., Nicholas, A. P., Gerasimcik, N., Lundberg, K., Klareskog, L., Catrina, A. I., & Yucel-Lindberg, T. (2018). Increased citrullination and expression of peptidylarginine deiminases independently of P. gingivalis and A. actinomycetemcomitans in gingival tissue of patients with periodontitis. Journal of Translational Medicine, 16, 214. https://doi.org/10.1186/s12967-018-1588-2
Cheng, Z., Do, T., Mankia, K., Meade, J., Hunt, L., Clerehugh, V., Speirs, A., Tugnait, A., Emery, P., & Devine, D. (2021). Dysbiosis in the oral microbiomes of anti-CCP positive individuals at risk of developing rheumatoid arthritis. Annals of the Rheumatic Diseases, 80(2), 162–168. https://doi.org/10.1136/annrheumdis-2020-216972
Sudhakara, P., Gupta, A., Bhardwaj, A., & Wilson, A. (2018). Oral dysbiotic communities and their implications in systemic diseases. Dentistry Journal, 6(2), 10. https://doi.org/10.3390/dj6020010Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C., & Kent, R. L., Jr. (1998). Microbial complexes in subgingival plaque. Journal of Clinical Periodontology, 25(2), 134–144. https://doi.org/10.1111/j.1600-051x.1998.tb02419.x
Socransky, S. S., Haffajee, A. D., Cugini, M. A., Smith, C., & Kent, R. L., Jr. (1998). Microbial complexes in subgingival plaque. Journal of Clinical Periodontology, 25(2), 134–144. https://doi.org/10.1111/j.1600-051x.1998.tb02419.x
Konig, M. F., Abusleme, L., Reinholdt, J., Palmer, R. J., Teles, R. P., Sampson, K., Rosen, A., Nigrovic, P. A., Sokolove, J., Giles, J. T., Moutsopoulos, N. M., & Andrade, F. (2016). Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Science Translational Medicine, 8(369), 369ra176. https://doi.org/10.1126/scitranslmed.aaj1921
Kozhakhmetov, S., Babenko, D., Issilbayeva, A., Nurgaziyev, M., Kozhakhmetova, S., Meiramova, A., Akhmetova, Z., Kunz, J., Ainabekova, B., & Marotta, F., Kushugulova, A. (2023). Oral microbial signature of rheumatoid arthritis in female patients. Journal of Clinical Medicine, 12(11), 3694. https://doi.org/10.3390/jcm12113694
Mikuls, T. R., Payne, J. B., Reinhardt, R. A., Thiele, G. M., Maziarz, E., Cannella, A. C., Holers, V. M., Kuhn, K. A., & O'Dell, J. R. (2008). Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis. International Immunopharmacology, 9(1), 38–42. https://doi.org/10.1016/j.intimp.2008.09.008
Hitchon, C. A., Chandad, F., Ferucci, E. D., Willemze, A., Ioan-Facsinay, A., van der Woude, D., Markland, J., Robinson, D., Elias, B., Newkirk, M., Toes, R. M., Huizinga, T. W. J., & El-Gabalawy, H. S. (2010). Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. Journal of Rheumatology, 37(6), 1105–1112. https://doi.org/10.3899/jrheum.091323
Bender, P., Bürgin, W. B., Sculean, A., & Eick, S. (2017). Serum antibody levels against Porphyromonas gingivalis in patients with and without rheumatoid arthritis - a systematic review and meta-analysis. Clinical Oral Investigations, 21(1), 33–42. https://doi.org/10.1007/s00784-016-1938-5
Moen, K., Brun, J. G., Madland, T. M., Tynning, T., & Jonsson, R. (2003). Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients. Clinical and Diagnostic Laboratory Immunology, 10(6), 1043–1050. https://doi.org/10.1128/CDLI.10.6.1043-1050.2003
Martinsson, K., Di Matteo, A., Öhman, C., Johansson, A., Svärd, A., Mankia, K., Emery, P., & Kastbom, A. (2023). Antibodies to leukotoxin A from the periodontal pathogen Aggregatibacter actinomycetemcomitans in patients at an increased risk of rheumatoid arthritis. Frontiers in Medicine, 10, 1176165. https://doi.org/10.3389/fmed.2023.1176165
Brewer, R. C., Lanz, T. V., Hale, C. R., Sepich-Poore, G. D., Martino, C., Swafford, A. D., Carroll, T. S., Kongpachith, S., Blum, L. K., Elliott, S. E., Blachere, N. E., Parveen, S., Fak, J., Yao, V., Troyanskaya, O., Frank, M. O., Bloom, M. S., Jahanbani, S., Gomez, A. M., Iyer, R., Ramadoss, N. S., Sharpe, O., Chandrasekaran, S., Kelmenson, L. B., Wang, Q., Wong, H., Torres, H. L., Wiesen, M., Graves, D. T., Deane, K. D., Holers, V. M., Knight, R., Darnell, R. B., Robinson, W. H., & Orange, D. E. (2023). Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis. Science Translational Medicine, 15(684), eabq8476. https://doi.org/10.1126/scitranslmed.abq8476
Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., Wu, X., Li, J., Tang, L., Li, Y., Lan, Z., Chen, B., Li, Y., Zhong, H., Xie, H., Jie, Z., Chen, W., Tang, S., Xu, X., Wang, X., Cai, X., Liu, S., Xia, Y., Li, J., Qiao, X., Al-Aama, J. Y., Chen, H., Wang, L., Wu, Q.-J., Zhang, F., Zheng, W., Li, Y., Zhang, M., Luo, G., Xue, W., Xiao, L., Li, J., Chen, W., Xu, X., Yin, Y., Yang, H., Wang, J., Kristiansen, K., Liu, L., Li, T., Huang, Q., Li, Y., & Wang, J. (2015). The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nature Medicine, 21(8), 895–905. https://doi.org/10.1038/nm.3914
Schmickler, J., Rupprecht, A., Patschan, S., Patschan, D., Müller, G. A., Haak, R., Mausberg, R. F., Schmalz, G., Kottmann, T., & Ziebolz, D. (2017). Cross-sectional evaluation of periodontal status and microbiologic and rheumatoid parameters in a large cohort of patients with rheumatoid arthritis. Journal of Periodontology, 88(4), 368–379. https://doi.org/10.1902/jop.2016.160355
Larsen, J. M. (2017). The immune response to Prevotella bacteria in chronic inflammatory disease. Immunology, 151(4), 363–374. https://doi.org/10.1111/imm.12760
Huang, Y., & Ni, S. (2023). Aggregatibacter actinomycetemcomitans with periodontitis and rheumatoid arthritis. International Dental Journal, 74(1), 58–65. https://doi.org/10.1016/j.identj.2023.06.011
Arleevskaya, M. I., Boulygina, E. A., Larionova, R., Validov, S., Kravtsova, O., Shagimardanova, E. I., Velo, L., Hery-Arnaud, G., Carlé, C., & Renaudineau, Y. (2022). Anti-citrullinated peptide antibodies control oral Porphyromonas and Aggregatibacter species in patients with rheumatoid arthritis. International Journal of Molecular Sciences, 23(20), 12599. https://doi.org/10.3390/ijms232012599
Tong, Y., Zheng, L., Qing, P., Zhao, H., Li, Y., Su, L., Zhang, Q., Zhao, Y., Luo, Y., & Liu, Y. (2020). Oral microbiota perturbations are linked to high risk for rheumatoid arthritis. Frontiers in Cellular and Infection Microbiology, 9, 475. https://doi.org/10.3389/fcimb.2019.00475
Esberg, A., Johansson, L., Johansson, I., & Rantapää Dahlqvist, S. (2021). Oral microbiota identifies patients in early onset rheumatoid arthritis. Microorganisms, 9(8), 1657. https://doi.org/10.3390/microorganisms9081657
Kroese, J. M., Brandt, B. W., Buijs, M. J., Crielaard, W., Lobbezoo, F., Loos, B. G., van Boheemen, L., van Schaardenburg, D., Zaura, E., & Volgenant, C. M. C. (2021). Differences in the oral microbiome in patients with early rheumatoid arthritis and individuals at risk of rheumatoid arthritis compared to healthy individuals. Arthritis & Rheumatology, 73(11), 1986–1993. https://doi.org/10.1002/art.41780
Beyer, K., Zaura, E., Brandt, B. W., Buijs, M. J., Brun, J. G., Crielaard, W., & Bolstad, A. I. (2018). Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health. PLoS One, 13(9), e0202278. https://doi.org/10.1371/journal.pone.0202278
Chen, B., Zhao, Y., Li, S., Yang, L., Wang, H., Wan, T., Shi, B., Gai, Z., Heng, X., Zhang, C., Yang, J., & Zhang, L. (2018). Variations in oral microbiome profiles in rheumatoid arthritis and osteoarthritis with potential biomarkers for arthritis screening. Scientific Reports, 8, 17126. https://doi.org/10.1038/s41598-018-35473-6
Silvestre-Rangil, J., Bagán, L., Silvestre, F. J., & Bagán, J. V. (2016). Oral manifestations of rheumatoid arthritis: A cross-sectional study of 73 patients. Clinical Oral Investigations, 20(9), 2575–2580. https://doi.org/10.1007/s00784-016-1745-z
Lopez-Oliva, I., Paropkari, A. D., Saraswat, S., Serban, S., Yonel, Z., Sharma, P., de Pablo, P., Raza, K., Filer, A., Chapple, I., Dietrich, T., Grant, M. M., & Kumar, P. S. (2018). Dysbiotic subgingival microbial communities in periodontally healthy patients with rheumatoid arthritis. Arthritis & Rheumatology, 70(7), 1008–1013. https://doi.org/10.1002/art.40485
Ghorbani, M., & Khoshdoozmasouleh, N. (2024). Distinct oral DNA viral signatures in rheumatoid arthritis: A pilot study. Journal of Oral Microbiology, 16(1), 2348260. https://doi.org/10.1080/20002297.2024.2348260
Li, S., Yu, Y., Yue, Y., Zhang, Z., & Su, K. (2013). Microbial infection and rheumatoid arthritis. Journal of Clinical & Cellular Immunology, 4(6), 174. https://doi.org/10.4172/2155-9899.1000174
Krutyhołowa, A., Strzelec, K., Dziedzic, A., Bereta, G. P., Łazarz-Bartyzel, K., Potempa, J., & Gawron, K. (2022). Host and bacterial factors linking periodontitis and rheumatoid arthritis. Frontiers in Immunology, 13, 980805. https://doi.org/10.3389/fimmu.2022.980805
Gao, L., Cheng, Z., Zhu, F., Bi, C., Shi, Q., & Chen, X. (2022). The oral microbiome and its role in systemic autoimmune diseases: A systematic review of big data analysis. Frontiers in Big Data, 5, 927520. https://doi.org/10.3389/fdata.2022.927520
Sandhya, P., Danda, D., Sharma, D., & Scaria, V. (2016). Does the buck stop with the bugs? An overview of microbial dysbiosis in rheumatoid arthritis. International Journal of Rheumatic Diseases, 19(1), 8–20. https://doi.org/10.1111/1756-185X.12728
Elsouri, K., Arboleda, V., Heiser, S., Kesselman, M. M., & Demory Beckler, M. (2021). Microbiome in rheumatoid arthritis and celiac disease: A friend or foe. Cureus, 13(6), e15543. https://doi.org/10.7759/cureus.15543
Erciyas, K., Sezer, U., Ustün, K., Pehlivan, Y., Kisacik, B., Senyurt, S. Z., Tarakçioğlu, M., & Onat, A. M. (2013). Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients. Oral Diseases, 19(4), 394–400. https://doi.org/10.1111/odi.12017
Okada, M., Kobayashi, T., Ito, S., Yokoyama, T., Abe, A., Murasawa, A., & Yoshie, H. (2013). Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis. Journal of Periodontology, 84(12), e74–e84. https://doi.org/10.1902/jop.2013.130079
Hu, W., Chen, S., Zou, X., Chen, Y., Luo, J., Zhong, P., & Ma, D. (2024). Oral microbiome, periodontal disease and systemic bone-related diseases in the era of homeostatic medicine. Journal of Advanced Research, S2090-1232(24)00362-X. https://doi.org/10.1016/j.jare.2024.08.019
Kulkarni, A., Beckler, M. D., Amini, S. S., & Kesselman, M. M. (2022). Oral microbiome in pre-rheumatoid arthritis: The role of Aggregatibacter actinomycetemcomitans in bacterial composition. Cureus, 14(12), e32201. https://doi.org/10.7759/cureus.32201
de Arruda, J. A. A., Corrêa, J. D., Singh, Y., Oliveira, S. R., Machado, C. C., Schneider, A. H., Medeiros, J. D., Fernandes, G. R., Macari, S., Barrioni, B. R., Santos, M. S., Duffles, L. F., Nakaya, H. T. I., Fukada, S. Y., Graves, D. T., Cunha, F. Q., & Silva, T. A. (2022). Methotrexate promotes recovery of arthritis-induced alveolar bone loss and modifies the composition of the oral-gut microbiota. Anaerobe, 75, 102577. https://doi.org/10.1016/j.anaerobe.2022.102577
Nik-Azis, N. M., Mohd, N., Mohd Fadzilah, F., Mohamed Hafla, N. H., Mohamed Said, M. S., & Baharin, B. (2021). Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study. PLoS One, 16(6), e0252859. https://doi.org/10.1371/journal.pone.0252859
Martu, M.-A., Maftei, G.-A., Luchian, I., Stefanescu, O. M., Scutariu, M. M., & Solomon, S. M. (2021). The effect of acknowledged and novel anti-rheumatic therapies on periodontal tissues—A narrative review. Pharmaceuticals (Basel), 14(12), 1209. https://doi.org/10.3390/ph14121209
Zamri, F., & de Vries, T. J. (2020). Use of TNF inhibitors in rheumatoid arthritis and implications for the periodontal status: For the benefit of both? Frontiers in Immunology, 11, 591365. https://doi.org/10.3389/fimmu.2020.591365
Ancuța, C., Pomîrleanu, C., Mihailov, C., Chirieac, R., Ancuța, E., Iordache, C., Bran, C., & Țănculescu, O. (2020). Efficacy of baricitinib on periodontal inflammation in patients with rheumatoid arthritis. Joint Bone Spine, 87(3), 235–239. https://doi.org/10.1016/j.jbspin.2019.12.003
Teoh, L., Moses, G., Nguyen, A. P., & McCullough, M. J. (2021). Medication-related osteonecrosis of the jaw: Analysing the range of implicated drugs from the Australian database of adverse event notifications. British Journal of Clinical Pharmacology, 87(7), 2767–2776. https://doi.org/10.1111/bcp.14681
Views:
28
Downloads:
13
Copyright (c) 2025 Hanna Adamska, Natalia Klepacz, Marta Kaus, Karina Grzesik, Hubert Sawczuk, Katarzyna Pilarczyk, Weronika Ewa Nowak, Aleksandra Rabęda, Marta Malicka, Zuzanna Cudziło
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
